Epigenetic Mechanisms as Emerging Therapeutic Targets and Microfluidic Chips Application in Pulmonary Arterial Hypertension

Pulmonary arterial hypertension (PAH) is a disease that progress over time and is defined as an increase in pulmonary arterial pressure and pulmonary vascular resistance that frequently leads to right-ventricular (RV) failure and death. Epigenetic modifications comprising DNA methylation, histone re...

Descripción completa

Detalles Bibliográficos
Autores principales: Ho, Linh, Hossen, Nazir, Nguyen, Trieu, Vo, Au, Ahsan, Fakhrul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773438/
https://www.ncbi.nlm.nih.gov/pubmed/35052850
http://dx.doi.org/10.3390/biomedicines10010170

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773438/
https://www.ncbi.nlm.nih.gov/pubmed/35052850
http://dx.doi.org/10.3390/biomedicines10010170

Ejemplares similares